Literature DB >> 22951448

World distribution, population genetics, and health burden of the hemoglobinopathies.

Thomas N Williams1, David J Weatherall.   

Abstract

Although information about the precise world distribution and frequency of the inherited hemoglobin disorders is still limited, there is no doubt that they are going to pose an increasing burden on global health resources in the future. Their high frequency is a reflection of natural selection combined with a high frequency of consanguineous marriages in many countries, together with an epidemiological transition; whereby, as public health measures improve in the poorer countries of the world, more babies with these disorders are surviving to present for treatment.

Entities:  

Mesh:

Year:  2012        PMID: 22951448      PMCID: PMC3426822          DOI: 10.1101/cshperspect.a011692

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  100 in total

1.  Protective effects of the sickle cell gene against malaria morbidity and mortality.

Authors:  Michael Aidoo; Dianne J Terlouw; Margarette S Kolczak; Peter D McElroy; Feiko O ter Kuile; Simon Kariuki; Bernard L Nahlen; Altaf A Lal; Venkatachalam Udhayakumar
Journal:  Lancet       Date:  2002-04-13       Impact factor: 79.321

2.  Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection.

Authors:  K Marsh; L Otoo; R J Hayes; D C Carson; B M Greenwood
Journal:  Trans R Soc Trop Med Hyg       Date:  1989 May-Jun       Impact factor: 2.184

3.  Reduced risk of uncomplicated malaria episodes in children with alpha+-thalassemia in northeastern Tanzania.

Authors:  Anders Enevold; John P Lusingu; Bruno Mmbando; Michael Alifrangis; Martha M Lemnge; Ib C Bygbjerg; Thor G Theander; Lasse S Vestergaard
Journal:  Am J Trop Med Hyg       Date:  2008-05       Impact factor: 2.345

4.  Malaria in patients with sickle cell anemia: burden, risk factors, and outcome at the outpatient clinic and during hospitalization.

Authors:  Julie Makani; Albert N Komba; Sharon E Cox; Julie Oruo; Khadija Mwamtemi; Jesse Kitundu; Pius Magesa; Stella Rwezaula; Elineema Meda; Josephine Mgaya; Kisali Pallangyo; Emelda Okiro; David Muturi; Charles R Newton; Gregory Fegan; Kevin Marsh; Thomas N Williams
Journal:  Blood       Date:  2009-11-09       Impact factor: 22.113

5.  Erythrocytic mechanism of sickle cell resistance to malaria.

Authors:  M J Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

6.  Associations between alpha+-thalassemia and Plasmodium falciparum malarial infection in northeastern Tanzania.

Authors:  Anders Enevold; Michael Alifrangis; Juan J Sanchez; Ilona Carneiro; Cally Roper; Claus Børsting; John Lusingu; Lasse S Vestergaard; Martha M Lemnge; Niels Morling; Eleanor Riley; Chris J Drakeley
Journal:  J Infect Dis       Date:  2007-06-20       Impact factor: 5.226

7.  Alteration in cytoadherence and rosetting of Plasmodium falciparum-infected thalassemic red blood cells.

Authors:  R Udomsangpetch; T Sueblinvong; K Pattanapanyasat; A Dharmkrong-at; A Kittikalayawong; H K Webster
Journal:  Blood       Date:  1993-12-15       Impact factor: 22.113

8.  Falciparum malaria and beta-thalassaemia trait in northern Liberia.

Authors:  M Willcox; A Björkman; J Brohult
Journal:  Ann Trop Med Parasitol       Date:  1983-08

Review 9.  The interaction of malaria parasites with red blood cells.

Authors:  G Pasvol; R J Wilson
Journal:  Br Med Bull       Date:  1982-05       Impact factor: 4.291

10.  Negative epistasis between α+ thalassaemia and sickle cell trait can explain interpopulation variation in South Asia.

Authors:  Bridget S Penman; Saman Habib; Kanika Kanchan; Sunetra Gupta
Journal:  Evolution       Date:  2011-08-11       Impact factor: 3.694

View more
  100 in total

1.  Sickle Cell and α+-Thalassemia Traits Influence the Association between Ferritin and Hepcidin in Rural Kenyan Children Aged 14-26 Months.

Authors:  Kendra A Byrd; Thomas N Williams; Audrie Lin; Amy J Pickering; Benjamin F Arnold; Charles D Arnold; Marion Kiprotich; Holly N Dentz; Sammy M Njenga; Gouthami Rao; John M Colford; Clair Null; Christine P Stewart
Journal:  J Nutr       Date:  2018-12-01       Impact factor: 4.798

Review 2.  Red blood cell components: time to revisit the sources of variability.

Authors:  Rosemary L Sparrow
Journal:  Blood Transfus       Date:  2017-03       Impact factor: 3.443

3.  [Hemoglobin disorders].

Authors:  R Dickerhoff
Journal:  Internist (Berl)       Date:  2015-09       Impact factor: 0.743

Review 4.  Clinical manifestations of α-thalassemia.

Authors:  Elliott P Vichinsky
Journal:  Cold Spring Harb Perspect Med       Date:  2013-05-01       Impact factor: 6.915

Review 5.  Omics Studies in Hemoglobinopathies.

Authors:  Eleni Katsantoni
Journal:  Mol Diagn Ther       Date:  2019-04       Impact factor: 4.074

6.  Genetics. GWAS to therapy by genome edits?

Authors:  Ross C Hardison; Gerd A Blobel
Journal:  Science       Date:  2013-10-11       Impact factor: 47.728

7.  Intestine-specific Disruption of Hypoxia-inducible Factor (HIF)-2α Improves Anemia in Sickle Cell Disease.

Authors:  Nupur Das; Liwei Xie; Sadeesh K Ramakrishnan; Andrew Campbell; Stefano Rivella; Yatrik M Shah
Journal:  J Biol Chem       Date:  2015-08-19       Impact factor: 5.157

Review 8.  Hemoglobin variants: biochemical properties and clinical correlates.

Authors:  Christopher S Thom; Claire F Dickson; David A Gell; Mitchell J Weiss
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

9.  Mechanism-driven phase I translational study of trifluoperazine in adults with sickle cell disease.

Authors:  Robert E Molokie; Diana J Wilkie; Harriett Wittert; Marie L Suarez; Yingwei Yao; Zhongsheng Zhao; Ying He; Zaijie J Wang
Journal:  Eur J Pharmacol       Date:  2013-11-07       Impact factor: 4.432

Review 10.  The hemoglobin E thalassemias.

Authors:  Suthat Fucharoen; David J Weatherall
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.